DANIEL G. WELCH

Insider Reports History

Location
Durham, NC
Signature
/s/ Jun Yoon, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by DANIEL G. WELCH:

Company Role Class Num Shares Value Price $ Report Date Ownership
Ultragenyx Pharmaceutical Inc. Director Common Stock 32,690 $1,241,566 $37.98 15 May 2025 Direct
Nuvation Bio Inc. Director Class A Common Stock 659,947 $1,082,313 $1.64 24 May 2024 Direct
Structure Therapeutics Inc. Director Share Option (right to buy) 51,804 23 Jun 2025 Direct
PROTHENA CORP PUBLIC LTD CO Director Stock Option (Right to Buy) 20,183 14 May 2025 Direct
Ultragenyx Pharmaceutical Inc. Director Stock Option (Right to Buy) 10,787 15 May 2025 Direct
Nuvation Bio Inc. Director Stock Option (Right to Buy) 0 24 May 2024 Direct
Seagen Inc. Director Common Stock 0 $229.00 14 Dec 2023 by Trust
Seagen Inc. Director Common Stock 0 $229.00 14 Dec 2023 Direct
Seagen Inc. Director Restricted Stock Units 0 $229.00 14 Dec 2023 Direct
Seagen Inc. Director Non-Qualified Stock Option (right to buy) 0 28 Aug 2023 Direct

Insider Reports Filed by DANIEL G. WELCH

Symbol Company Period Transactions Value $ Form Type Role Filing Time
GPCR Structure Therapeutics Inc. 23 Jun 2025 1 $0 4 Director 25 Jun 2025, 17:45
RARE Ultragenyx Pharmaceutical Inc. 15 May 2025 2 $0 4 Director 19 May 2025, 18:33
PRTA PROTHENA CORP PUBLIC LTD CO 14 May 2025 1 $0 4 Director 16 May 2025, 16:57
GPCR Structure Therapeutics Inc. 25 Jun 2024 1 $0 4 Director 27 Jun 2024, 16:15
RARE Ultragenyx Pharmaceutical Inc. 18 Jun 2024 2 $0 4 Director 20 Jun 2024, 14:25
NUVB Nuvation Bio Inc. 24 May 2024 4 $1,111,633 4 Director 29 May 2024, 16:38
PRTA PROTHENA CORP PUBLIC LTD CO 15 May 2024 1 $0 4 Director 17 May 2024, 16:44
PRTA PROTHENA CORP PUBLIC LTD CO 21 Feb 2024 1 $0 4 Director 23 Feb 2024, 17:37
PRTA PROTHENA CORP PUBLIC LTD CO 21 Feb 2024 0 $0 3 Director 23 Feb 2024, 17:36
SGEN Seagen Inc. 14 Dec 2023 3 $3,543,775 4 Director 15 Dec 2023, 18:31
SGEN Seagen Inc. 28 Aug 2023 5 $783,951 4 Director 29 Aug 2023, 18:22
GPCR Structure Therapeutics Inc. 03 Aug 2023 3 $0 4 Director 04 Aug 2023, 17:37
RARE Ultragenyx Pharmaceutical Inc. 07 Jun 2023 2 $0 4 Director 09 Jun 2023, 14:28
SGEN Seagen Inc. 31 May 2023 1 $0 4 Director 02 Jun 2023, 18:18
NUVB Nuvation Bio Inc. 15 May 2023 1 $0 4 Director 17 May 2023, 17:15
SGEN Seagen Inc. 15 May 2023 3 $120,023 4 Director 16 May 2023, 19:23
SGEN Seagen Inc. 01 May 2023 19 $3,823,058 4 Director 03 May 2023, 21:16
SGEN Seagen Inc. 03 Apr 2023 0 $0 4/A Director 12 Apr 2023, 20:03
SGEN Seagen Inc. 15 Mar 2023 5 $641,704 4 Director 17 Mar 2023, 16:43
SGEN Seagen Inc. 13 Mar 2023 23 $4,877,286 4 Director 16 Mar 2023, 06:05
GPCR Structure Therapeutics Inc. 07 Feb 2023 2 $0 4 Director 09 Feb 2023, 18:12
GPCR Structure Therapeutics Inc. 02 Feb 2023 0 $0 3 Director 02 Feb 2023, 17:23
RARE Ultragenyx Pharmaceutical Inc. 24 Jun 2022 2 $0 4 Director 28 Jun 2022, 13:54
NUVB Nuvation Bio Inc. 16 May 2022 1 $0 4/A Director 28 Jun 2022, 19:11
SGEN Seagen Inc. 13 May 2022 2 $0 4 Director 17 May 2022, 19:28
SGEN Seagen Inc. 31 Dec 2021 2 $0 5 Director 11 Feb 2022, 16:19
NUVB Nuvation Bio Inc. 29 Oct 2021 1 $0 4 Director 02 Nov 2021, 21:31
RARE Ultragenyx Pharmaceutical Inc. 24 Jun 2021 2 $0 4 Director 28 Jun 2021, 18:27
SGEN Seagen Inc. 14 May 2021 2 $0 4 Director 18 May 2021, 19:22